Murepavadin clinical trials
Also written POL7080.
How each study uses murepavadin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2013 (3)
| Year | Studies |
|---|---|
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Polyphor Ltd. (6) · Hoffmann-La Roche (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses murepavadin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas AeruginosaTerminatedPhase 3Polyphor Ltd.NCT03409679Written as Murepavadin
- Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to PseudomonasTerminatedPhase 3Polyphor Ltd.NCT03582007Written as Murepavadin
- Pharmacokinetics, Safety and Efficacy of POL7080 in Patients With Ventilator Associated Pseudomonas Aeruginosa PneumoniaCompletedPhase 2Polyphor Ltd.NCT02096328Written as POL7080
- DDI Study to Investigate Interaction Between Amikacin and POL7080CompletedPhase 1Polyphor Ltd.NCT02897869Written as POL7080
- Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.TerminatedPhase 2Polyphor Ltd.NCT02096315Written as POL7080
- A Phase 1 Clinical Study in Healthy Volunteers to Investigate the Drug-drug Interaction Between Multiple Doses of RO7033877 and Multiple Doses of Colistin Methanesulfonate Sodium (CMS)CompletedPhase 1Hoffmann-La RocheNCT02156323Written as RO7033877
- Pharmacokinetics and Safety of POL7080 in Patients With Renal ImpairmentCompletedPhase 1Polyphor Ltd.NCT02110459Written as POL7080
Codes
What other systems call murepavadin · ClinicalTrials.gg INT001032
- MeSH (NLM) C000629572murepavadinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 0D02GRY87ZMUREPAVADINConfirmed FDA, NLM, Wikidata
- Wikidata Q27236621murepavadinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C175150MurepavadinOne source FDA
- DrugBank DB14777One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000629572 | murepavadin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 0D02GRY87Z | MUREPAVADIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27236621 | murepavadin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C175150 | Murepavadin | One source FDA |
| DrugBank | DB14777 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.